Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

  • Exchange: NASDAQ GM
  • Sector: Health Care
  • Industry: Medical Equipment & Devices
  • Sub-Industry: Medical Devices

ATRC:US

21.2000 USD 0.1400 0.66%

As of 20:10:00 ET on 03/27/2015.

Snapshot for AtriCure Inc (ATRC)

Open: 21.1000 Day's Range: 20.9100 - 21.6800 Volume: 196,167
Previous Close: 21.0600 52wk Range: 13.1850 - 22.9740 1-Yr Rtn: +17.13%

Stock Chart for ATRC

No chart data available.
  • ATRC:US 21.2000
  • 1D
  • 1M
  • 1Y
21.0600
Interactive ATRC Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for ATRC

Current P/E Ratio (ttm) -
Estimated P/E(12/2015) -
Relative P/E vs. SPX -
Earnings Per Share (USD) (ttm) -0.7536
Est. EPS (USD) (12/2015) -0.8270
Est. PEG Ratio -
Market Cap (M USD) 584.92
Shares Outstanding (M) 27.59
30 Day Average Volume 170,483
Price/Book (mrq) 4.4115
Price/Sale (ttm) 5.2037
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 04/24/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for ATRC

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for ATRC

AtriCure, Inc. develops, manufactures, and sells surgical devices designed to create precise lesions in soft tissues. The Company's bipolar ablation system is used by cardiothoracic surgeons as a standard treatment alternative to create lesions in heart tissue to block the abnormal electrical impulses that cause atrial fibrillation.

Michael H Carrel "Mike"President/CEODouglas J Seith "Doug"Chief Operating Officer
Andrew L LuxSenior VP:OperationsPatricia J KennedyVP/Gen Mgr:International
More Company Profile & Key Executives for ATRC

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil